相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Matrix metalloproteinase 9 gene haplotypes affect left ventricular hypertrophy in hypertensive patients
Riccardo Lacchini et al.
CLINICA CHIMICA ACTA (2010)
Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents
Vanessa A. Belo et al.
CLINICAL BIOCHEMISTRY (2009)
Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension
Michele M. Castro et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients
C. Demacq et al.
PHARMACOGENOMICS JOURNAL (2009)
Angiogenesis and obesity
H. Roger Lijnen
CARDIOVASCULAR RESEARCH (2008)
Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects
Caroline Demacq et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Dose-dependent beneficial hemodynamic effects of BAY 41-2272 in a canine model of acute pulmonary thromboembolism
Stefany B. A. Cau et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents
Barbara Glowinska-Olszewska et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Mechanisms linking obesity with cardiovascular disease
Luc F. Van Gaal et al.
NATURE (2006)
Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old
Kenneth F. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects
C Demacq et al.
CLINICA CHIMICA ACTA (2006)
Atherosclerosis and proteinase activation
CM Dollery et al.
CARDIOVASCULAR RESEARCH (2006)
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension
MLL Martinez et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Rational inferences about departures from Hardy-Weinberg equilibrium
JK Wittke-Thompson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages
M Kumada et al.
CIRCULATION (2004)
Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease
S Blankenberg et al.
CIRCULATION (2003)
Score tests for association between traits and haplotypes when linkage phase is ambiguous
DJ Schaid et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene -: An autopsy study
PJ Pöllänen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
分享论文
